Results 261 to 270 of about 57,177 (346)

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Preemptive fixation of a jejunal enteral tube extension via novel anchoring system. [PDF]

open access: yesEndoscopy
Rozenberg J   +5 more
europepmc   +1 more source

Multivisceral allotransplantation in pigs [PDF]

open access: yes, 1996
Furukawa, H   +4 more
core  

Expressive language and social communication abilities in children with spinal muscular atrophy type 1

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 5, Page 696-705, May 2026.
Abstract Aim To investigate parent‐reported expressive language and social communication abilities in children with spinal muscular atrophy type 1 (SMA1) treated with disease‐modifying therapies. Method This was a cross‐sectional feasibility study performed at the Dubowitz Neuromuscular Centre, London (UK), and the Centro Clinico Nemo Pediatrico, Rome (
Chiara Brusa   +19 more
wiley   +1 more source

Symptomatic Pneumoperitoneum After Percutaneous Radiological Gastrostomy in Patient With Duchenne Disease Dependent on Non-Invasive Mechanical Ventilation. [PDF]

open access: yesOpen Respir Arch
Lozano Cuesta P   +4 more
europepmc   +1 more source

Surgical and health outcomes of non‐ambulatory children with cerebral palsy and severe scoliosis: A population‐based, longitudinal study

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 5, Page 681-687, May 2026.
Abstract Aim To evaluate medium‐term surgical outcomes, complications, mortality, and health‐related quality of life (HRQoL) in non‐ambulatory children with cerebral palsy (CP) and severe scoliosis, and to analyse outcomes and mortality rates in children who had not undergone surgery.
Svend Vinje   +4 more
wiley   +1 more source

A Clinical Practice Update for the Management of Patients With Disorders of Gut‐Brain Interaction and Altered Food Intake Behavior

open access: yesNeurogastroenterology &Motility, Volume 38, Issue 5, May 2026.
ABSTRACT Background Disorders of Gut‐Brain Interaction (DGBI) impact as many as one in three individuals at some stage of their lives. Clinically, patients with DGBI may present with meal‐related symptoms that progressively lead to altered food intake behaviors, resulting in subsequent weight loss and nutritional deficiencies.
Ayesha Shah   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy